Rusnano plans $900 mln pharmaceuticals project with British partners - Chubais
MOSCOW. Nov 25 (Interfax) - The Russian state corporation Rusnano is planning out a $900 million pharmaceuticals project with partners from Britain, Rusnano chief Anatoly Chubais told the press.
"What we're talking about is creating Russian big-pharma together with British partners," Chubais said. He provided no further details, as project negotiations are yet ongoing.
"We're not interested in generics, we are only interested in innovative pharmaceuticals," Chubais said.